Search research articles
Contact Us
Filters
Showing results (381-390 of 399) with videos related to
Page
of 40
Sort By:
Mayo Clinic Proceedings
|
February 13, 2026
Utility of Next-Generation Sequencing in Renal Neoplasia, Including Tumors With Clear Cytoplasm and Rare Phenotypes (ELOC/MITF Alterations and Mismatch Repair Deficiency)
Michael McCarthy, Antonina A Wojcik, Emily G Barr Fritcher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 1, 2021
Phase II Evaluation of Stereotactic Ablative Radiotherapy (SABR) and Immunity in <sup>11</sup>C-Choline-PET/CT-Identified Oligometastatic Castration-Resistant Prostate Cancer
Henan Zhang, Jacob J Orme, Feven Abraha, et al.
Prostate Cancer and Prostatic Diseases
|
February 27, 2024
Genomic attributes of prostate cancer across primary and metastatic noncastrate and castrate resistant disease states: a next generation sequencing study of 183 patients
Surendra Dasari, Michael R McCarthy, Antonina A Wojcik, et al.
Cancer
|
March 25, 2021
Active surveillance of metastatic renal cell carcinoma: Results from a prospective observational study (MaRCC)
Michael R Harrison, Brian A Costello, Nrupen A Bhavsar, et al.
JAMA Oncology
|
January 27, 2022
Development and Assessment of a Predictive Score for Vertebral Compression Fracture After Stereotactic Body Radiation Therapy for Spinal Metastases
Roman O Kowalchuk, Benjamin A Johnson-Tesch, Joseph T Marion, et al.
European Urology
|
October 4, 2002
Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care--the Triumph project
K M C Verhamme, J P Dieleman, G S Bleumink, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 28, 2024
Randomized trial of anetumab ravtansine and pembrolizumab compared to pembrolizumab for mesothelioma
Aaron S Mansfield, Jun Vivien Yin, Penelope Bradbury, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 10, 2017
Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology
Robert J Motzer, Eric Jonasch, Neeraj Agarwal, et al.
Cancer
|
December 26, 2022
Development and validation of a recursive partitioning analysis-based pretreatment decision-making tool identifying ideal candidates for spine stereotactic body radiation therapy
Roman O Kowalchuk, Trey C Mullikin, Marcus Florez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 28, 2018
Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)
Brigette B Y Ma, Wan-Teck Lim, Boon-Cher Goh, et al.
Page
of 40
Search research articles
Search
Showing results (381-390 of 399) with videos related to
Sort By:
Page
of 40
Mayo Clinic Proceedings
|
February 13, 2026
Utility of Next-Generation Sequencing in Renal Neoplasia, Including Tumors With Clear Cytoplasm and Rare Phenotypes (ELOC/MITF Alterations and Mismatch Repair Deficiency)
Michael McCarthy, Antonina A Wojcik, Emily G Barr Fritcher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 1, 2021
Phase II Evaluation of Stereotactic Ablative Radiotherapy (SABR) and Immunity in <sup>11</sup>C-Choline-PET/CT-Identified Oligometastatic Castration-Resistant Prostate Cancer
Henan Zhang, Jacob J Orme, Feven Abraha, et al.
Prostate Cancer and Prostatic Diseases
|
February 27, 2024
Genomic attributes of prostate cancer across primary and metastatic noncastrate and castrate resistant disease states: a next generation sequencing study of 183 patients
Surendra Dasari, Michael R McCarthy, Antonina A Wojcik, et al.
Cancer
|
March 25, 2021
Active surveillance of metastatic renal cell carcinoma: Results from a prospective observational study (MaRCC)
Michael R Harrison, Brian A Costello, Nrupen A Bhavsar, et al.
JAMA Oncology
|
January 27, 2022
Development and Assessment of a Predictive Score for Vertebral Compression Fracture After Stereotactic Body Radiation Therapy for Spinal Metastases
Roman O Kowalchuk, Benjamin A Johnson-Tesch, Joseph T Marion, et al.
European Urology
|
October 4, 2002
Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care--the Triumph project
K M C Verhamme, J P Dieleman, G S Bleumink, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 28, 2024
Randomized trial of anetumab ravtansine and pembrolizumab compared to pembrolizumab for mesothelioma
Aaron S Mansfield, Jun Vivien Yin, Penelope Bradbury, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 10, 2017
Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology
Robert J Motzer, Eric Jonasch, Neeraj Agarwal, et al.
Cancer
|
December 26, 2022
Development and validation of a recursive partitioning analysis-based pretreatment decision-making tool identifying ideal candidates for spine stereotactic body radiation therapy
Roman O Kowalchuk, Trey C Mullikin, Marcus Florez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 28, 2018
Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)
Brigette B Y Ma, Wan-Teck Lim, Boon-Cher Goh, et al.
Page
of 40